top of page

News & Insights
Search


How to draft a liability cap that actually caps: four drafting fixes that prevent most disputes
Today’s post looks like it is for the contract nerds. It is not. If you sign contracts, negotiate them, or get dragged into the “can’t we just close this?” call, this one is for you. Topic: liability caps . The clause everyone claims is non-negotiable until the moment they negotiate it for four weeks. The clause that somehow manages to be both (i) “market standard” and (ii) the reason your deal has been stuck in legal review since the last ice age. Everyone focuses on the nu
Jan 5


License agreement checklist: the 10 sections you need to review on every deal
Life sciences thrive on innovation, and licensing is the backbone of bringing that innovation to market. But here’s the thing: license agreements are often seen as dense legal documents, full of jargon and clauses that seem unnecessary. Yet, these agreements are critical for defining how intellectual property (IP) is shared, protected, and commercialized. Get them wrong, and you’re looking at disputes, lost revenue, or even legal battles. So, what makes these agreements so tr
Dec 17, 2025


If your AI remembers too much, it might break the law: Germany’s GEMA v. OpenAI ruling & What life sciences should know about AI copyright risk
If your company is building its own large language model (LLM) for applications like drug discovery, biomarker identification, or clinical trial optimization, this case should be on your radar. A recent ruling by the Munich Regional Court (LG München v. 11.11.2025 – 42 O 14139/24 – GEMA vs. Open AI) —while not yet legally binding—sends a clear signal: training LLMs on protected works constitutes copyright infringement under German law, unless narrow legal exceptions apply . T
Dec 3, 2025


Understanding licensing in Life Sciences: What Matters to Different Stakeholders
Licensing is one of the most powerful tools in the life sciences industry - yet no two deals look the same. Whether you’re a biotech...
Feb 2, 2025


10 Tips for Better CDAs (Part 2)
Last week, we gave you five tips on how to improve your confidential disclosure agreements ( "10 Tips for Better CDAs (Part 1)" ). Here...
Dec 29, 2024


10 Tips for Better CDAs (Part 1)
A Confidential Disclosure Agreement (CDA) is one of the most widely-used agreements in the life sciences sector. It is also an important...
Dec 22, 2024


Help: My licensor is bankrupt!
With a patent license, the licensee receives permission to use the licensed patent. But what happens if the licensor becomes insolvent?...
May 27, 2022


How to Divorce Amicably - On Termination in a License Deal
License agreements are like prenuptial agreements: They are concluded for a long time and with great expectations - and people are...
Mar 9, 2022


BGH: No Patent Protection for (Genetic) Test Results
Genetic testing or DNA testing is becoming ever more important – for predicting or diagnosing diseases, for preparing patient-specific...
Feb 17, 2022
bottom of page
